These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7701822)

  • 41. The role of compatibility tests. (Report of a meeting sponsored by the Bureau of Biologics for the Blood Products Advisory Committee).
    Garratty G
    Transfusion; 1982; 22(2):169-72. PubMed ID: 6803410
    [No Abstract]   [Full Text] [Related]  

  • 42. Elimination of pretransfusion RhD typing at Mackay Memorial Hospital, Taiwan-30-year experience (1988-2017).
    Lin M
    Vox Sang; 2021 Feb; 116(2):234-238. PubMed ID: 32951225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [MSBOS and T & S--their significance and practice].
    Sekiguchi S; Kasai S
    Rinsho Byori; 1991 Mar; Suppl 88():82-6. PubMed ID: 1906952
    [No Abstract]   [Full Text] [Related]  

  • 44. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Revised guidelines for compatibility testing in hospital blood banks: important changes for quality assurance and procedures.
    Voak D; Waters AH
    Clin Lab Haematol; 1990; 12(2):235-6. PubMed ID: 2119933
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation of the value of compatibility tests before blood transfusion].
    Delajlija-Kostić M
    Acta Med Iugosl; 1983; 37(5):393-409. PubMed ID: 6666673
    [No Abstract]   [Full Text] [Related]  

  • 47. Twelve years of the Brazilian External Quality Assessment Program in Immunohematology: benefits of the program.
    Melo L; Pellegrino J; Bianco C; Castilho L
    J Clin Lab Anal; 2005; 19(5):209-18. PubMed ID: 16170810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-stage papain-indirect antiglobulin test and LISS direct agglutination are not appropriate for pretransfusion screening for unexpected antibodies.
    Pereira A; Mazzara R; Gelabert A; Castillo R
    Haematologica; 1991; 76(6):475-8. PubMed ID: 1820984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Importance of molecular RhD genotyping in transfusion medicine].
    Drazić V
    Lijec Vjesn; 2007 May; 129 Suppl 3():58-9. PubMed ID: 18972637
    [No Abstract]   [Full Text] [Related]  

  • 50. [Limits of routine blood group serology in perinatal diagnosis].
    Wangerin R; Diekamp U
    Beitr Infusionsther; 1990; 26():367-9. PubMed ID: 1703873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Where are we in efforts to unravel the complexity of Rh to guide transfusion decisions?
    Nance ST; Lomas-Francis C
    Transfusion; 2013 Nov; 53(11 Suppl 2):2840-3. PubMed ID: 24011221
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients.
    Legler TJ; Eber SW; Lakomek M; Lynen R; Maas JH; Pekrun A; Repas-Humpe M; Schröter W; Köhler M
    Transfusion; 1999 Aug; 39(8):852-5. PubMed ID: 10504121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. International forums--an Australian perspective.
    Ford DS
    Vox Sang; 1996; 70(4):239-40. PubMed ID: 9123934
    [No Abstract]   [Full Text] [Related]  

  • 54. Increase of blood donations found positive in the direct antiglobulin test detected by column methods--do we need to know?
    Boulton FE
    Br J Biomed Sci; 1996 Jun; 53(2):172-3. PubMed ID: 8757697
    [No Abstract]   [Full Text] [Related]  

  • 55. Proficiency testing in immunohematology in Ontario, Canada, 1975-1977.
    Pinkerton PH; Wood DE; Burnie KL; Carstairs KC; Croucher BE; Ezer S; Ley DC; McBride JA; Murray JF; Quantz MC
    Am J Clin Pathol; 1979 Oct; 72(4):559-63. PubMed ID: 115311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Critical analysis of the routine use of the direct antiglobulin test in 22,517 cross-matching tests].
    López J; Fernández Villalta MJ; de la Calle C; Biurrum M; Gómez-Reino F; Fernández-Rañada JM
    Sangre (Barc); 1990 Feb; 35(1):15-7. PubMed ID: 2333579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Erythrocyte detection with the immunoperoxidase method following 2 failed transfusions in ABO and Rhesus incompatibility--clinical course].
    Heim MU; Pachmann U; Böck M; Geschwändler E; Schleifer A; Eckstein R; Mempel W
    Beitr Infusionsther; 1988; 21():255-8. PubMed ID: 2462987
    [No Abstract]   [Full Text] [Related]  

  • 58. Predonation screening and pretransfusion testing.
    Woodfield G
    Vox Sang; 1994; 67 Suppl 5():20-7. PubMed ID: 7701821
    [No Abstract]   [Full Text] [Related]  

  • 59. A renewed understanding of anti-human globulin reagents: interference constraints using an optimization method in pretransfusion compatibility tests.
    Wang SS; Zhang H; Qu L; Zhao Z; Li L
    J Clin Lab Anal; 2021 Mar; 35(3):e23695. PubMed ID: 33543811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for microplate techniques in liquid-phase blood grouping and antibody screening. A Joint Publication of the British Society for Haematology and the British Blood Transfusion Society. BCSH Blood Transfusion Task Force.
    Clin Lab Haematol; 1990; 12(4):437-60. PubMed ID: 2127909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.